Published in J Pharmacol Exp Ther on July 15, 2015
Highly Selective Dopamine D3 Receptor (D3R) Antagonists and Partial Agonists Based on Eticlopride and the D3R Crystal Structure: New Leads for Opioid Dependence Treatment. J Med Chem (2016) 0.75
Towards understanding the structural basis of partial agonism at the dopamine D3 receptor. J Med Chem (2016) 0.75
Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet (2002) 40.37
Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci U S A (1988) 11.96
Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics. Nature (1990) 6.18
The projections of the ventral tegmental area and adjacent regions: a combined fluorescent retrograde tracer and immunofluorescence study in the rat. Brain Res Bull (1983) 5.23
Current perspectives on selective dopamine D(3) receptor antagonists as pharmacotherapeutics for addictions and related disorders. Ann N Y Acad Sci (2010) 2.36
Dopamine D3 receptor antagonism inhibits cocaine-seeking and cocaine-enhanced brain reward in rats. J Neurosci (2002) 1.84
The role of central dopamine D3 receptors in drug addiction: a review of pharmacological evidence. Brain Res Brain Res Rev (2005) 1.80
Adaptive increase in D3 dopamine receptors in the brain reward circuits of human cocaine fatalities. J Neurosci (1996) 1.78
Renal D3 dopamine receptor stimulation induces natriuresis by endothelin B receptor interactions. Kidney Int (2008) 1.63
An improved method to correct the QT interval of the electrocardiogram for changes in heart rate. J Pharmacol Methods (1989) 1.58
D3 receptor binding in human brain during cocaine overdose. Mol Psychiatry (1997) 1.55
Imaging dopamine D3 receptors in the human brain with positron emission tomography, [11C]PHNO, and a selective D3 receptor antagonist. Biol Psychiatry (2010) 1.50
The dopamine D3 receptor and drug dependence: effects on reward or beyond? Neuropharmacology (2005) 1.43
Acute administration of SB-277011A, NGB 2904, or BP 897 inhibits cocaine cue-induced reinstatement of drug-seeking behavior in rats: role of dopamine D3 receptors. Synapse (2005) 1.43
Selective dopamine D3 receptor antagonism by SB-277011A attenuates cocaine reinforcement as assessed by progressive-ratio and variable-cost-variable-payoff fixed-ratio cocaine self-administration in rats. Eur J Neurosci (2005) 1.37
Disruption of the dopamine D3 receptor gene produces renin-dependent hypertension. J Clin Invest (1998) 1.34
Functional genomics of the dopaminergic system in hypertension. Physiol Genomics (2004) 1.32
Principles of safety pharmacology. Br J Pharmacol (2008) 1.27
Pharmacological actions of NGB 2904, a selective dopamine D3 receptor antagonist, in animal models of drug addiction. CNS Drug Rev (2007) 1.21
Brain mechanisms of drug reward and euphoria. Psychiatr Med (1985) 1.21
YQA14: a novel dopamine D3 receptor antagonist that inhibits cocaine self-administration in rats and mice, but not in D3 receptor-knockout mice. Addict Biol (2011) 1.16
Heightened D3 dopamine receptor levels in cocaine dependence and contributions to the addiction behavioral phenotype: a positron emission tomography study with [11C]-+-PHNO. Neuropsychopharmacology (2013) 1.16
Acute administration of the selective D3 receptor antagonist SB-277011A blocks the acquisition and expression of the conditioned place preference response to heroin in male rats. Synapse (2003) 1.11
Dopamine D3 and D2 receptor mechanisms in the abuse-related behavioral effects of cocaine: studies with preferential antagonists in squirrel monkeys. J Pharmacol Exp Ther (2010) 1.09
Selective antagonism at dopamine D3 receptors attenuates cocaine-seeking behaviour in the rat. Int J Neuropsychopharmacol (2006) 1.06
Dopamine and renal function and blood pressure regulation. Compr Physiol (2011) 1.06
Cocaine intoxication. Crit Care Clin (2012) 1.03
The preferential dopamine D3 receptor antagonist S33138 inhibits cocaine reward and cocaine-triggered relapse to drug-seeking behavior in rats. Neuropharmacology (2009) 0.98
Occupancy of brain dopamine D3 receptors and drug craving: a translational approach. Neuropsychopharmacology (2012) 0.97
Cocaine use and risk of stroke: a systematic review. Drug Alcohol Depend (2014) 0.96
The peripheral dopaminergic system: morphological analysis, functional and clinical applications. Ital J Anat Embryol (2002) 0.95
Rationale in support of the use of selective dopamine D₃ receptor antagonists for the pharmacotherapeutic management of substance use disorders. Naunyn Schmiedebergs Arch Pharmacol (2012) 0.93
1,2,4-Triazolyl azabicyclo[3.1.0]hexanes: a new series of potent and selective dopamine D(3) receptor antagonists. J Med Chem (2010) 0.92
Selective dopamine D3 receptor antagonists: a review 2001-2005. Recent Pat CNS Drug Discov (2006) 0.92
Cocaine: history, social implications, and toxicity: a review. Semin Diagn Pathol (2009) 0.92
[3H]quinpirole binding to putative D2 and D3 dopamine receptors in rat brain and pituitary gland: a quantitative autoradiographic study. J Pharmacol Exp Ther (1993) 0.92
Dopamine D3 receptor activation modulates renal function in anesthetized rats. Naunyn Schmiedebergs Arch Pharmacol (1998) 0.89
Dopamine D3 receptor ligands for the treatment of tobacco dependence. Expert Opin Investig Drugs (2007) 0.89
Dopamine D3 receptor agents as potential new medications for drug addiction. Eur Psychiatry (2000) 0.88
D3 dopamine receptor regulation of ETB receptors in renal proximal tubule cells from WKY and SHRs. Am J Hypertens (2009) 0.87
The effects of the novel DA D3 receptor antagonist SR 21502 on cocaine reward, cocaine seeking and cocaine-induced locomotor activity in rats. Psychopharmacology (Berl) (2013) 0.86
The novel dopamine D3 receptor antagonist, SR 21502, reduces cocaine conditioned place preference in rats. Neurosci Lett (2014) 0.83
The heterogeneity of ventral tegmental area neurons: Projection functions in a mood-related context. Neuroscience (2014) 0.83
Blockade of D3 receptors by YQA14 inhibits cocaine's rewarding effects and relapse to drug-seeking behavior in rats. Neuropharmacology (2013) 0.82
Dopamine D3 receptor inhibits the ubiquitin-specific peptidase 48 to promote NHE3 degradation. FASEB J (2013) 0.82
The dopamine D3 receptor knockout mouse mimics aging-related changes in autonomic function and cardiac fibrosis. PLoS One (2013) 0.82
A multi-site comparison of in vivo safety pharmacology studies conducted to support ICH S7A & B regulatory submissions. J Pharmacol Toxicol Methods (2013) 0.79
Pharmacokinetics and central nervous system effects of the novel dopamine D3 receptor antagonist GSK598809 and intravenous alcohol infusion at pseudo-steady state. J Psychopharmacol (2012) 0.77
Absence of amino acid-induced glomerular hyperfiltration in dopamine D3 receptor knockout mice. Naunyn Schmiedebergs Arch Pharmacol (2005) 0.76